substitution for "narrow therapeutic index" (NTI) drugs
The new generic warfarin is raising a big controversy about substitution for "narrow therapeutic index" (NTI) drugs.
It's true that some drugs have a narrow range between doses that are subpotent...and doses that are toxic. Warfarin is one.
There are others...carbamazepine...digoxin...levothyroxine...phenytoin...theophylline.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote